Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959620 · ClinicalTrials.gov registry record · NA
Optimal Dose of Early Intervention to Prevent PTSD
A NA study of Posttraumatic Stress Disorder, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 1
- Study location
NCT01959620 is a NA study of Posttraumatic Stress Disorder that has completed, run by Emory University. The registered enrollment target is 95 participants, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01959620, a NA study of Posttraumatic Stress Disorder, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this study is to determine the optimal dose, 3-session exposure intervention versus 1-session exposure intervention compared to no treatment, for the delivery of exposure therapy in the immediate aftermath of trauma for preventing the development of posttraumatic stress disorder.
Conditions Studied
Interventions
- BEHAVIORAL 1-Session Exposure Therapy
- BEHAVIORAL 3-Session Exposure Therapy
Study Locations (1)
Georgia
- Grady Memorial Hospital, Emergency Department - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01959620
The ClinicalTrials.gov registry entry for NCT01959620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (14% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which 1-Session Exposure Therapy is the first listed.
NCT01959620 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT01959620 about?
NCT01959620 is a clinical study titled "Optimal Dose of Early Intervention to Prevent PTSD". The overall aim of this study is to determine the optimal dose, 3-session exposure intervention versus 1-session exposure intervention compared to no treatment, for the delivery of exposure therapy in the immediate aftermath of trauma for preventing the development of posttraumatic stress disorder.
What is the current status of trial NCT01959620?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2013-10. Estimated completion is 2016-12.
What conditions does trial NCT01959620 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder.
What interventions are being tested in trial NCT01959620?
The interventions under investigation include: 1-Session Exposure Therapy (BEHAVIORAL), 3-Session Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01959620?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01959620 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Impact of Cognitive Behavioral Therapy on PTSD-CVD Link
RECRUITING · NA
-
A Mechanistic Trial of the Neurobiology of Extinction Learning and Intraparietal Sulcus Stimulation
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.